---
title: O11 biomedical
date: 2024-03-12T13:12:52Z
modified: 2026-08-11T11:28:34Z
permalink: "https://www.htgf.de/en/portfolio/htgffamily/o11-biomedical/"
type: portfolio
status: publish
excerpt: ""
wpid: 113359
language:
  - English
post_translations:
  - pll_660feac4ec77c
branchen22:
  - Emergency Care
sectors:
  - MedTech
  - Pharmaceuticals
focus_areas:
  - Drug Delivery
  - Emergency care
  - Gastrointestinal
  - New Materials
timestamp: 2026-08-11T11:28:34Z
tags:
  - English
  - pll_660feac4ec77c
  - Emergency Care
  - MedTech
  - Pharmaceuticals
  - Drug Delivery
  - Emergency care
  - Gastrointestinal
  - New Materials
---

## Beschreibungstext

O11 biomedical, a visionary medical technology start-up that emerged as part of BioTex at RWTH Aachen University/ University Hospital Aachen 2022, aims to improve survival rates and quality of life for patients struggling with severe respiratory distress. O11 has developed a disruptive therapy that allows patients to „breathe out“ carbon dioxide via the intestines, freeing them from hours of agonizing ventilation therapy: RESPILIQ™. With currently 6 employees and its own production and development facility in Aachen, O11 is ideally positioned for the future.

## Unternehmenswebsite

https://o11-biomedical.com

## Adresse

Schlossparkstr. 93
52072 Aachen

## Kontakt

Array

Array